APO Research
Talk to an analyst

APO RESEARCH · REPORT

Axillary Hyperhidrosis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Axillary Hyperhidrosis Drug Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchAxillary Hyperhidrosis Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Axillary Hyperhidrosis Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Axillary Hyperhidrosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Axillary Hyperhidrosis Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Axillary Hyperhidrosis Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Axillary Hyperhidrosis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Axillary Hyperhidrosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Axillary Hyperhidrosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Axillary Hyperhidrosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Axillary Hyperhidrosis Drug include GlaxoSmithKline Plc, TheraVida Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, Dermira Inc, Brickell Biotech Inc and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Axillary Hyperhidrosis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Axillary Hyperhidrosis Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Axillary Hyperhidrosis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Axillary Hyperhidrosis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Axillary Hyperhidrosis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Axillary Hyperhidrosis Drug Market by Company

GlaxoSmithKline Plc

TheraVida Inc

Dr. August Wolff GmbH & Co KG Arzneimittle

Dermira Inc

Brickell Biotech Inc

Allergan Plc

Axillary Hyperhidrosis Drug Segment by Type

Botulinum ToxinA

Glycopyrronium Tosylate

Glycopyrrolate

Others

Axillary Hyperhidrosis Drug Segment by Application

Home Care

Hospital

Clinic

Axillary Hyperhidrosis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Axillary Hyperhidrosis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Axillary Hyperhidrosis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Axillary Hyperhidrosis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Axillary Hyperhidrosis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Axillary Hyperhidrosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Botulinum ToxinA Table 2. Major Company of Glycopyrronium Tosylate Table 3. Major Company of Glycopyrrolate Table 4. Major Company of Others Table 5. Global Axillary Hyperhidrosis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (k units) Table 7. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Axillary Hyperhidrosis Drug Price by Type (2021-2026) & (US$/unit) Table 11. Global Axillary Hyperhidrosis Drug Sales by Type (2027-2032) & (k units) Table 12. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Axillary Hyperhidrosis Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Axillary Hyperhidrosis Drug Price by Type (2027-2032) & (US$/unit) Table 16. North America Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (k units) Table 17. North America Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (k units) Table 19. Europe Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (k units) Table 23. Latin America Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Axillary Hyperhidrosis Drug Industry Trends Table 27. Axillary Hyperhidrosis Drug Industry Drivers Table 28. Axillary Hyperhidrosis Drug Industry Opportunities and Challenges Table 29. Axillary Hyperhidrosis Drug Industry Restraints Table 30. Global Axillary Hyperhidrosis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Axillary Hyperhidrosis Drug Revenue Market Share by Company (2021-2026) Table 32. Global Axillary Hyperhidrosis Drug Sales by Company (2021-2026) & (k units) Table 33. Global Axillary Hyperhidrosis Drug Sales Share by Company (2021-2026) Table 34. Global Axillary Hyperhidrosis Drug Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Axillary Hyperhidrosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Axillary Hyperhidrosis Drug Major Company Production Sites and Headquarters Table 37. Global Axillary Hyperhidrosis Drug Company, Product Type & Application Table 38. Global Axillary Hyperhidrosis Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Axillary Hyperhidrosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Axillary Hyperhidrosis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Axillary Hyperhidrosis Drug Sales by Region (2021-2026) & (k units) Table 43. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Axillary Hyperhidrosis Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Axillary Hyperhidrosis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Axillary Hyperhidrosis Drug Sales by Region (2027-2032) & (k units) Table 48. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Axillary Hyperhidrosis Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Axillary Hyperhidrosis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Axillary Hyperhidrosis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (k units) Table 54. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Axillary Hyperhidrosis Drug Price by Application (2021-2026) & (US$/unit) Table 58. Global Axillary Hyperhidrosis Drug Sales by Application (2027-2032) & (k units) Table 59. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Axillary Hyperhidrosis Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Axillary Hyperhidrosis Drug Price by Application (2027-2032) & (US$/unit) Table 63. North America Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (k units) Table 64. North America Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (k units) Table 66. Europe Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (k units) Table 70. Latin America Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 73. GlaxoSmithKline Plc Company Information Table 74. GlaxoSmithKline Plc Business Overview Table 75. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Portfolio Table 77. GlaxoSmithKline Plc Recent Development Table 78. TheraVida Inc Company Information Table 79. TheraVida Inc Business Overview Table 80. TheraVida Inc Axillary Hyperhidrosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. TheraVida Inc Axillary Hyperhidrosis Drug Product Portfolio Table 82. TheraVida Inc Recent Development Table 83. Dr. August Wolff GmbH & Co KG Arzneimittle Company Information Table 84. Dr. August Wolff GmbH & Co KG Arzneimittle Business Overview Table 85. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Portfolio Table 87. Dr. August Wolff GmbH & Co KG Arzneimittle Recent Development Table 88. Dermira Inc Company Information Table 89. Dermira Inc Business Overview Table 90. Dermira Inc Axillary Hyperhidrosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Dermira Inc Axillary Hyperhidrosis Drug Product Portfolio Table 92. Dermira Inc Recent Development Table 93. Brickell Biotech Inc Company Information Table 94. Brickell Biotech Inc Business Overview Table 95. Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Portfolio Table 97. Brickell Biotech Inc Recent Development Table 98. Allergan Plc Company Information Table 99. Allergan Plc Business Overview Table 100. Allergan Plc Axillary Hyperhidrosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Allergan Plc Axillary Hyperhidrosis Drug Product Portfolio Table 102. Allergan Plc Recent Development Table 103. North America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 104. North America Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 105. North America Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2026) Table 106. North America Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 107. North America Axillary Hyperhidrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 108. North America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Axillary Hyperhidrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Axillary Hyperhidrosis Drug Market Share by Country (2021-2026) Table 111. North America Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Axillary Hyperhidrosis Drug Market Share Forecast by Country (2027-2032) Table 113. Europe Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. Europe Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 115. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2026) Table 116. Europe Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 117. Europe Axillary Hyperhidrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Axillary Hyperhidrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Axillary Hyperhidrosis Drug Market Share by Country (2021-2026) Table 121. Europe Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Axillary Hyperhidrosis Drug Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 125. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 127. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Axillary Hyperhidrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Axillary Hyperhidrosis Drug Market Share by Country (2021-2026) Table 131. Asia-Pacific Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Axillary Hyperhidrosis Drug Market Share Forecast by Country (2027-2032) Table 133. Latin America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Latin America Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 135. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2026) Table 136. Latin America Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 137. Latin America Axillary Hyperhidrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Axillary Hyperhidrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Axillary Hyperhidrosis Drug Market Share by Country (2021-2026) Table 141. Latin America Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Axillary Hyperhidrosis Drug Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 145. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 147. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Axillary Hyperhidrosis Drug Market Share by Country (2021-2026) Table 151. Middle East and Africa Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Axillary Hyperhidrosis Drug Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Axillary Hyperhidrosis Drug Distributors List Table 156. Axillary Hyperhidrosis Drug Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Axillary Hyperhidrosis Drug Image Figure 2. Global Axillary Hyperhidrosis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Axillary Hyperhidrosis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Axillary Hyperhidrosis Drug Sales (2021-2032) & (k units) Figure 5. Botulinum ToxinA Image Figure 6. Global Botulinum ToxinA Sales YoY Growth (2021-2032) & (k units) Figure 7. Glycopyrronium Tosylate Image Figure 8. Global Glycopyrronium Tosylate Sales YoY Growth (2021-2032) & (k units) Figure 9. Glycopyrrolate Image Figure 10. Global Glycopyrrolate Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Axillary Hyperhidrosis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Axillary Hyperhidrosis Drug Market Share by Type 2025 VS 2032 Figure 15. North America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Axillary Hyperhidrosis Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Home Care Image Figure 28. Global Home Care Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Axillary Hyperhidrosis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Axillary Hyperhidrosis Drug Market Share by Application 2025 VS 2032 Figure 35. North America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Axillary Hyperhidrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Axillary Hyperhidrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Axillary Hyperhidrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Axillary Hyperhidrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Axillary Hyperhidrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Axillary Hyperhidrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Axillary Hyperhidrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Axillary Hyperhidrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Axillary Hyperhidrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Axillary Hyperhidrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Axillary Hyperhidrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Axillary Hyperhidrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Axillary Hyperhidrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Axillary Hyperhidrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Axillary Hyperhidrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Axillary Hyperhidrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Axillary Hyperhidrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Axillary Hyperhidrosis Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Axillary Hyperhidrosis Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Botulinum ToxinA
  • Glycopyrronium Tosylate
  • Glycopyrrolate
  • Others
Applications
  • Home Care
  • Hospital
  • Clinic
Companies covered
  • GlaxoSmithKline Plc
  • TheraVida Inc
  • Dr. August Wolff GmbH & Co KG Arzneimittle
  • Dermira Inc
  • Brickell Biotech Inc
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Axillary Hyperhidrosis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Axillary Hyperhidrosis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Axillary Hyperhidrosis Drug Market by Type
  6. 1.3.1 Botulinum ToxinA
  7. 1.3.2 Glycopyrronium Tosylate
  8. 1.3.3 Glycopyrrolate
  9. 1.3.4 Others
  10. 1.4 Global Axillary Hyperhidrosis Drug Market Size by Type
  11. 1.4.1 Global Axillary Hyperhidrosis Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Axillary Hyperhidrosis Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Axillary Hyperhidrosis Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Axillary Hyperhidrosis Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Axillary Hyperhidrosis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Axillary Hyperhidrosis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Axillary Hyperhidrosis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Axillary Hyperhidrosis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Axillary Hyperhidrosis Drug Industry Trends
  2. 2.2 Axillary Hyperhidrosis Drug Industry Drivers
  3. 2.3 Axillary Hyperhidrosis Drug Industry Opportunities and Challenges
  4. 2.4 Axillary Hyperhidrosis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Axillary Hyperhidrosis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Axillary Hyperhidrosis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Axillary Hyperhidrosis Drug Price (2021-2026)
  4. 3.4 Global Axillary Hyperhidrosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Axillary Hyperhidrosis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Axillary Hyperhidrosis Drug Company, Product Type & Application
  7. 3.7 Global Axillary Hyperhidrosis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Axillary Hyperhidrosis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Axillary Hyperhidrosis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Axillary Hyperhidrosis Drug Tier 1, Tier 2, and Tier 3
4 Axillary Hyperhidrosis Drug Regional Status and Outlook
  1. 4.1 Global Axillary Hyperhidrosis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Axillary Hyperhidrosis Drug Historic Market Size by Region
  3. 4.2.1 Global Axillary Hyperhidrosis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Axillary Hyperhidrosis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Axillary Hyperhidrosis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Axillary Hyperhidrosis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Axillary Hyperhidrosis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Axillary Hyperhidrosis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Axillary Hyperhidrosis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Axillary Hyperhidrosis Drug by Application
  1. 5.1 Axillary Hyperhidrosis Drug Market by Application
  2. 5.1.1 Home Care
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Axillary Hyperhidrosis Drug Market Size by Application
  6. 5.2.1 Global Axillary Hyperhidrosis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Axillary Hyperhidrosis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Axillary Hyperhidrosis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Axillary Hyperhidrosis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Axillary Hyperhidrosis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Axillary Hyperhidrosis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Axillary Hyperhidrosis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Axillary Hyperhidrosis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline Plc
  2. 6.1.1 GlaxoSmithKline Plc Company Information
  3. 6.1.2 GlaxoSmithKline Plc Business Overview
  4. 6.1.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Portfolio
  6. 6.1.5 GlaxoSmithKline Plc Recent Developments
  7. 6.2 TheraVida Inc
  8. 6.2.1 TheraVida Inc Company Information
  9. 6.2.2 TheraVida Inc Business Overview
  10. 6.2.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TheraVida Inc Axillary Hyperhidrosis Drug Product Portfolio
  12. 6.2.5 TheraVida Inc Recent Developments
  13. 6.3 Dr. August Wolff GmbH & Co KG Arzneimittle
  14. 6.3.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
  15. 6.3.2 Dr. August Wolff GmbH & Co KG Arzneimittle Business Overview
  16. 6.3.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Portfolio
  18. 6.3.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Developments
  19. 6.4 Dermira Inc
  20. 6.4.1 Dermira Inc Company Information
  21. 6.4.2 Dermira Inc Business Overview
  22. 6.4.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dermira Inc Axillary Hyperhidrosis Drug Product Portfolio
  24. 6.4.5 Dermira Inc Recent Developments
  25. 6.5 Brickell Biotech Inc
  26. 6.5.1 Brickell Biotech Inc Company Information
  27. 6.5.2 Brickell Biotech Inc Business Overview
  28. 6.5.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Portfolio
  30. 6.5.5 Brickell Biotech Inc Recent Developments
  31. 6.6 Allergan Plc
  32. 6.6.1 Allergan Plc Company Information
  33. 6.6.2 Allergan Plc Business Overview
  34. 6.6.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Allergan Plc Axillary Hyperhidrosis Drug Product Portfolio
  36. 6.6.5 Allergan Plc Recent Developments
7 North America by Country
  1. 7.1 North America Axillary Hyperhidrosis Drug Sales by Country
  2. 7.1.1 North America Axillary Hyperhidrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Axillary Hyperhidrosis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Axillary Hyperhidrosis Drug Market Size by Country
  6. 7.2.1 North America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Axillary Hyperhidrosis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Axillary Hyperhidrosis Drug Sales by Country
  2. 8.1.1 Europe Axillary Hyperhidrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Axillary Hyperhidrosis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Axillary Hyperhidrosis Drug Market Size by Country
  6. 8.2.1 Europe Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Axillary Hyperhidrosis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Axillary Hyperhidrosis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Axillary Hyperhidrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Axillary Hyperhidrosis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Axillary Hyperhidrosis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Axillary Hyperhidrosis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Axillary Hyperhidrosis Drug Sales by Country
  2. 10.1.1 South America Axillary Hyperhidrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Axillary Hyperhidrosis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Axillary Hyperhidrosis Drug Market Size by Country
  6. 10.2.1 South America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Axillary Hyperhidrosis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Axillary Hyperhidrosis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Axillary Hyperhidrosis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Axillary Hyperhidrosis Drug Value Chain Analysis
  2. 12.1.1 Axillary Hyperhidrosis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Axillary Hyperhidrosis Drug Production Mode & Process
  7. 12.2 Axillary Hyperhidrosis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Axillary Hyperhidrosis Drug Distributors
  10. 12.2.3 Axillary Hyperhidrosis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst